Dr. Daniela Marino
Advertisement
Articles by Dr. Daniela Marino
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Moving CAR-T Beyond Oncology
3
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
4
Cautious Momentum: Biopharma Review and Outlook
5